Table of Contents 15 sections Group Mechanism of Action Dose Rates Dog Cat Horse Cattle Ferret Rabbit Indications Contraindications Interactions Adverse effects Preparations Monitoring and Administration
Famotidine Famotidine is a histamine H2-receptor antagonist used for gastric acid suppression. Veterinary applications involve selected acid-related upper gastrointestinal disorders in dogs, cats and other species. Its effect can be useful for short-term reduction of acid exposure, although the magnitude and persistence of suppression vary with the patient, route and duration of administration.
H2-receptor antagonist
Famotidine blocks histamine H2 receptors on gastric parietal cells. Reduced receptor signaling lowers cyclic-AMP-mediated activation of the acid-secretory pathway, decreasing basal and stimulated gastric acid output. A higher gastric pH reduces acid exposure of damaged gastric, duodenal or esophageal mucosa. The principal effect is suppression of acid secretion rather than direct treatment of the emetic reflex.
Dog Use / stage Dose Route Schedule Instructions Acid suppression 0.5 mg/kg PO, IV, IM, SC Every 12 h Acid suppression 1 mg/kg PO Every 12 h Higher oral alternative; therapeutic pH targets are not consistently achieved. Acid suppression 40 mg/animal PO Every 12 h Empirical fixed alternative. Acid suppression infusion — Loading 1 mg/kg IV Acid suppression infusion — Maintenance 0.3333333333 mg/kg/hour IV Continuous Equivalent to 8 mg/kg per 24 hours.
Cat Use / stage Dose Route Schedule Instructions Acid suppression 0.2 mg/kg PO, IV, IM, SC Every 24 h Acid suppression 0.25 mg/kg PO, IV, IM, SC Every 12 h Alternative higher-frequency regimen; IV slowly over 5 minutes.
Horse Use / stage Dose Route Schedule Instructions Acid suppression 1–2 mg/kg PO Every 6–8 h Acid suppression 0.2–0.4 mg/kg IV Every 6 h Gastric ulcer adjunct 0.23 mg/kg IV Every 8 h Gastric ulcer adjunct 0.35 mg/kg IV Every 12 h Gastric ulcer adjunct 1.88 mg/kg PO Every 8 h Gastric ulcer adjunct 2.8 mg/kg PO Every 12 h
Cattle Use / stage Dose Route Schedule Instructions Acid suppression 0.4 mg/kg IV Every 6 h
Ferret Use / stage Dose Route Schedule Instructions Stress-associated ulceration 0.25–0.5 mg/kg PO, IV Every 24 h
Rabbit Use / stage Dose Route Schedule Instructions Stress-ulcer prevention 1 mg/kg IV Every 24 h After stabilization of the critically ill rabbit.
Short-term gastric acid suppression in selected dogs and cats with suspected or documented acid-related gastroduodenal injury. Adjunctive reduction of acid exposure in reflux esophagitis. Management of selected gastric hypersecretory states, including gastrinoma or histamine-associated hypersecretion in mast-cell disease. Adjust for impaired renal clearance. Reduced acidity can impair absorption of azoles and iron. Potential CNS effects at excessive exposure Rapid injection reactions, especially with benzyl-alcohol formulations in cats Preparation Form Strength Route Famotidine 20 mg Tablet 20 mg / tablet PO Famotidine 40 mg Tablet 40 mg / tablet PO Famotidine suspension 8 mg/mL Oral Liquid 8 mg / mL PO Famotidine injection 10 mg/mL Injection 10 mg / mL IV, IM, SC
Oral acid suppression may diminish with repeated dosing; PPIs generally provide more reliable suppression. It is not an established antiemetic.
Administer feline IV doses slowly, around 5 minutes. Monitor response and renal status.
Source-described saline dilutions are stable for 48 hours at room temperature; compounded oral stability depends on vehicle.